Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Low-level laser therapy: Case-control study in dogs with sterile pyogranulomatous pododermatitis

Given the positive results of this first clinical study, it would be interesting to extend the study to confirm the validity of this type of therapy in sterile pyogranulomatous pododermatitis in the dog.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors ran a pilot study of low-level laser therapy in five dogs with sterile pyogranulomatous pododermatitis, comparing laser-treated lesions with lesions treated with a steroid spray. They report that treated lesions improved over time and were more improved than control lesions at day 4 and day 20, with no adverse reactions recorded. The authors describe the results as positive but call for a larger study to confirm them, given the very small sample.

Participants
5
Who or what was studied
Five dogs with sterile pyogranulomatous pododermatitis
Limits stated in the abstract
Very small pilot study of five dogs with a control-lesion design, and the authors state that the findings need confirmation in a larger study.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Aim

Low-level laser therapy (LLLT) is a therapeutic photobiostimulation with properties in reducing swelling, inflammation, and promoting tissue healing. The objective of this pilot study was to evaluate LLLT in sterile pyogranulomatous pododermatitis in five dogs.

Materials And Methods

In each dog, one lesion was designated as the control (treated with a 0.0584% hydrocortisone aceponate spray), and one or more other lesions were treated with a gallium aluminum arsenide-laser, daily for 5 days. Lesions were scored before treatment (D0), at the end (D4), 16 days after the last laser treatment (D20), and after 2 months (D65).

Results

Comparing the treated lesion group with the control lesion group, the clinical score was similar at D0, whereas there was a statistically significant difference at D4 and D20; in the treated group over time, there was a statistically significant improvement between D0, D4, and D20. Lesion recurrence was absent in more than 50% of the treated lesions at D65. No adverse reactions were reported.

Conclusion

Given the positive results of this first clinical study, it would be interesting to extend the study to confirm the validity of this type of therapy in sterile pyogranulomatous pododermatitis in the dog.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Low-level laser therapy, Laser, Inflammation, Pilot study. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies